The Gateway to Your Orthopaedic Recovery.

Author listing

Meet our authors and contributors and explore their latest articles, insights, and expertise
Editor-in-Chief

Editor-in-Chief 's Latest Stories

Rheumatoid arthritis is an autoimmune disease whereby the body's own immune system attacks the joints. New research suggests there may be a link between mothers with the autoimmune disorder and their...
Here are three things to know about Dr. Rubright: 1. He specializes in the treatment of hand, wrist, elbow and shoulder conditions. 2. He holds memberships with American Academy of Orthopaedic Surgeon...
Dr. Bosita serves as the chairman of the board of managers at Texas Health Presbyterian Hospital Rockwall. His research, which focuses on orthopedic fracture care, has been accepted for publication in...
Here's what you should know. 1. Northwestern Medicine entered into a multi-year partnership with the Cougars. 2. During this time, the field will bear the Northwestern Medicine name and the health sys...
Here's what you need to know. 1. The Peach Bowl is one of the semifinal games during the College Football Playoff Championship. The peach bowl is the ninth-oldest college football game in the country,...
Here are five highlights: 1. Premier Pain and Spine hopes its sponsorship role will extend its reach to people in need of its services. 2. Premier Pain and Spine centers offer pain management services...
For the first time, a multicentre study headed up by MedUni Vienna has compared the action of two rheumatoid arthritis drugs from the same class. The study established that the two TNF inhibitors inve...
Researchers at the University of Rochester Medical Center believe they have identified a new means of enhancing the body's ability to repair its own cells, which they hope will lead to better diagnosi...
Here's what you need to know. 1. The Pinnacle of Excellence Award recognizes top healthcare organizations on the basis of achievement and high levels of excellence concerning patient experience. The G...
UCB and Amgen have announced results from the Phase 3 BRIDGE study showing that in men with osteoporosis , the investigational agent romosozumab resulted in significant bone mineral density (BMD) gain...